Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Siddiqui, M.S. Lai, Z.M. Spain, L. Greener, V. Turajlic, S. Larkin, J. Morganstein, D.L. (2021). Predicting development of ipilimumab-induced hypophysitis: utility of T4 and TSH index but not TSH. Journal of endocrinological investigation, Vol.44 (1), pp. 195-203.  show abstract

Gudd, C.L. Au, L. Triantafyllou, E. Shum, B. Liu, T. Nathwani, R. Kumar, N. Mukherjee, S. Dhar, A. Woollard, K.J. Yone, Y. Pinato, D.J. Thursz, M.R. Goldin, R.D. Gore, M.E. Larkin, J. Khamri, W. Antoniades, C.G. Turajlic, S. Possamai, L.A. (2021). Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis. Journal of hepatology, .

Litchfield, K. Reading, J.L. Puttick, C. Thakkar, K. Abbosh, C. Bentham, R. Watkins, T.B. Rosenthal, R. Biswas, D. Rowan, A. Lim, E. Al Bakir, M. Turati, V. Guerra-Assunção, J.A. Conde, L. Furness, A.J. Saini, S.K. Hadrup, S.R. Herrero, J. Lee, S.-. Van Loo, P. Enver, T. Larkin, J. Hellmann, M.D. Turajlic, S. Quezada, S.A. McGranahan, N. Swanton, C. (2021). Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition. Cell, Vol.184 (3), pp. 596-614.e14.

Edwards, C.L. Comito, F. Agraso Busto, S. Harland, C. Turajlic, S. Larkin, J. Heelan, K. Fearfield, L. (2021). Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review The experience of a single large specialist institution. Clinical and experimental dermatology, Vol.46 (2), pp. 338-341.

Rzeniewicz, K. Larkin, J. Menzies, A.M. Turajlic, S. (2021). Immunotherapy use outside clinical trial populations: never say never?. Annals of oncology, .

O’Reilly, A. Hughes, P. Mann, J. Lai, Z. Teh, J.J. Mclean, E. Edmonds, K. Lingard, K. Chauhan, D. Lynch, J. Au, L. Ludlow, A. Pattison, N. Wiseman, T. Turajlic, S. Gore, M. Larkin, J. Husson, O. (2020). An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors. Supportive care in cancer, Vol.28 (2), pp. 561-570.

Watkins, T.B. Lim, E.L. Petkovic, M. Elizalde, S. Birkbak, N.J. Wilson, G.A. Moore, D.A. Grönroos, E. Rowan, A. Dewhurst, S.M. Demeulemeester, J. Dentro, S.C. Horswell, S. Au, L. Haase, K. Escudero, M. Rosenthal, R. Bakir, M.A. Xu, H. Litchfield, K. Lu, W.T. Mourikis, T.P. Dietzen, M. Spain, L. Cresswell, G.D. Biswas, D. Lamy, P. Nordentoft, I. Harbst, K. Castro-Giner, F. Yates, L.R. Caramia, F. Jaulin, F. Vicier, C. Tomlinson, I.P. Brastianos, P.K. Cho, R.J. Bastian, B.C. Dyrskjøt, L. Jönsson, G.B. Savas, P. Loi, S. Campbell, P.J. Andre, F. Luscombe, N.M. Steeghs, N. Tjan-Heijnen, V.C. Szallasi, Z. Turajlic, S. Jamal-Hanjani, M. Van Loo, P. Bakhoum, S.F. Schwarz, R.F. McGranahan, N. Swanton, C. (2020). Pervasive chromosomal instability and karyotype order in tumour evolution. Nature, Vol.587 (7832), pp. 126-132.

Litchfield, K. Stanislaw, S. Spain, L. Gallegos, L.L. Rowan, A. Schnidrig, D. Rosenbaum, H. Harle, A. Au, L. Hill, S.M. Tippu, Z. Thomas, J. Thompson, L. Xu, H. Horswell, S. Barhoumi, A. Jones, C. Leith, K.F. Burgess, D.L. Watkins, T.B. Lim, E. Birkbak, N.J. Lamy, P. Nordentoft, I. Dyrskjøt, L. Pickering, L. Hazell, S. Jamal-Hanjani, M. Larkin, J. Swanton, C. Alexander, N.R. Turajlic, S. Abbosh, C. Shiu, K.-. Bridgewater, J. Hochhauser, D. Forster, M. Lee, S.-. Ahmad, T. Papadatos-Pastos, D. Janes, S. Van Loo, P. Enfield, K. McGranahan, N. Huebner, A. Quezada, S. Beck, S. Parker, P. Walczak, H. Enver, T. Hynds, R. Falzon, M. Proctor, I. Sinclair, R. Lok, C.-. Rhodes, Z. Moore, D. Marafioti, T. Borg, E. Mitchison, M. Khiroya, R. Trevisan, G. Ellery, P. Linch, M. Brandner, S. Hiley, C. Veeriah, S. Razaq, M. Shaw, H. Attard, G. Akther, M.A. Naceur-Lombardelli, C. Manzano, L. Al-Bakir, M. Summan, S. Kanu, N. Ward, S. Asghar, U. Lim, E. Gishen, F. Tookman, A. Stone, P. Stirling, C. Furness, A. Edmonds, K. Hunter, N. Sarker, S. Vaughan, S. Mangwende, M. Pearce, K. Spain, L. Shepherd, S. Yan, H. Shum, B. Carlyle, E. Hazell, S. Fendler, A. Byrne, F. Yousaf, N. Popat, S. Curtis, O. Stamp, G. Toncheva, A. Nye, E. Murra, A. Korteweg, J. Sheikh, N. Josephs, D. Chandra, A. Spicer, J. Mahadeva, U. Green, A. Stewart, R. Iredale, L.-. Mackay, T. Deakin, B. Enting, D. Rudman, S. Ghosh, S. Karapagniotou, L. Pintus, E. Tutt, A. Howlett, S. Michalarea, V. Brenton, J. Caldas, C. Fitzgerald, R. Jimenez-Linan, M. Provenzano, E. Cluroe, A. Stewart, G. Watts, C. Gilbertson, R. McDermott, U. Tavare, S. Beddowes, E. Roxburgh, P. Biankin, A. Chalmers, A. Fraser, S. Oien, K. Kidd, A. Blyth, K. Krebs, M. Blackhall, F. Summers, Y. Dive, C. Marais, R. Gomes, F. Carter, M. Dransfield, J. Le Quesne, J. Fennell, D. Shaw, J. Naidu, B. Baijal, S. Tanchel, B. Langman, G. Robinson, A. Collard, M. Cockcroft, P. Ferris, C. Bancroft, H. Kerr, A. Middleton, G. Webb, J. Kadiri, S. Colloby, P. Olisemeke, B. Wilson, R. Tomlinson, I. Jogai, S. Ottensmeier, C. Harrison, D. Loda, M. Flanagan, A. McKenzie, M. Hackshaw, A. Ledermann, J. Sharp, A. Farrelly, L. Bridger, H. (2020). Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue. Cell reports, Vol.31 (5), pp. 107550-107550.

Powell, N. Ibraheim, H. Raine, T. Speight, R.A. Papa, S. Brain, O. Green, M. Samaan, M.A. Spain, L. Yousaf, N. Hunter, N. Eldridge, L. Pavlidis, P. Irving, P. Hayee, B. Turajlic, S. Larkin, J. Lindsay, J.O. Gore, M. (2020). British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis. The lancet gastroenterology & hepatology, Vol.5 (7), pp. 679-697.

Comito, F. Leslie, I. Boos, L. Furness, A. Pickering, L. Turajlic, S. Larkin, J. (2020). Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective Analysis. Journal of immunotherapy, Vol.43 (8), pp. 250-255.

Rini, B. Abel, E.J. Albiges, L. Bex, A. Brugarolas, J. Bukowski, R.M. Coleman, J.A. Drake, C.G. Figlin, R.A. Futreal, A. Hammers, H. Powles, T. Rathmell, W.K. Ricketts, C.J. Turajlic, S. Wood, C.G. Leibovich, B.C. (2020). Summary from the Kidney Cancer Association’s Inaugural Think Thank: Coalition for a Cure. Clinical genitourinary cancer, .

Litchfield, K. Reading, J.L. Lim, E.L. Xu, H. Liu, P. Al-Bakir, M. Wong, Y.N. Rowan, A. Funt, S.A. Merghoub, T. Perkins, D. Lauss, M. Svane, I.M. Jönsson, G. Herrero, J. Larkin, J. Quezada, S.A. Hellmann, M.D. Turajlic, S. Swanton, C. (2020). Escape from nonsense-mediated decay associates with anti-tumor immunogenicity. Nature communications, Vol.11 (1).

Spain, L. Tippu, Z. Larkin, J.M. Carr, A. Turajlic, S. (2020). How we treat neurological toxicity from immune checkpoint inhibitors. Esmo open, Vol.4, pp. e000540-e000540.

Favara, D.M. Spain, L. Au, L. Clark, J. Daniels, E. Diem, S. Chauhan, D. Turajlic, S. Powell, N. Larkin, J.M. Yousaf, N. (2020). Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma. Esmo open, Vol.5 (4), pp. e000585-e000585.

Shepherd, S.T. Litchfield, K. Turajlic, S. (2019). Searching for the needle in the haystack: deconvoluting the evolutionary dynamics of residual disease in human glioblastoma. Annals of oncology, Vol.30 (3), pp. 355-357.

Turajlic, S. (2019). Standing on the shoulders of giants. Nature medicine, Vol.25 (3), pp. 357-357.

Turajlic, S. Sottoriva, A. Graham, T. Swanton, C. (2019). Resolving genetic heterogeneity in cancer. Nat rev genet, Vol.20 (7), pp. 404-416.  show abstract

Amaria, R.N. Menzies, A.M. Burton, E.M. Scolyer, R.A. Tetzlaff, M.T. Antdbacka, R. Ariyan, C. Bassett, R. Carter, B. Daud, A. Faries, M. Fecher, L.A. Flaherty, K.T. Gershenwald, J.E. Hamid, O. Hong, A. Kirkwood, J.M. Lo, S. Margolin, K. Messina, J. Postow, M.A. Rizos, H. Ross, M.I. Rozeman, E.A. Saw, R.P. Sondak, V. Sullivan, R.J. Taube, J.M. Thompson, J.F. van de Wiel, B.A. Eggermont, A.M. Davies, M.A. Ascierto, P.A. Spillane, A.J. van Akkooi, A.C. Wargo, J.A. Blank, C.U. Tawbi, H.A. Long, G.V. Andrews, M.C. Berry, D.A. Block, M.S. Boland, G.M. Bollin, K.B. Carlino, M.S. Carvajal, R.D. Cohen, J. Davar, D. Delman, K.A. Dummer, R. Farwell, M.D. Fisher, D.E. Fusi, A. Glitza, I.C. de Gruijl, T.D. Gyorki, D.E. Hauschild, A. Hieken, T.J. Larkin, J. Lawson, D.H. Lebbe, C. Lee, J.E. Lowe, M.C. Luke, J.J. McArthur, G.A. McDermott, D.F. McQuade, J.L. Mitchell, T.C. Petrella, T.M. Prieto, P.A. Puzanov, I. Robert, C. Salama, A.K. Sandhu, S. Schadendorf, D. Shoushtari, A.N. Sosman, J.A. Swetter, S.M. Tanabe, K.K. Turajlic, S. Tyler, D.S. Woodman, S.E. Wright, F.C. Zager, J.S. (2019). Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. The lancet oncology, Vol.20 (7), pp. e378-e389.

Turajlic, S. Swanton, C. Boshoff, C. (2018). Kidney cancer: The next decade. Journal of experimental medicine, Vol.215 (10), pp. 2477-2479.  show abstract

Flynn, M. Pickering, L. Larkin, J. Turajlic, S. (2018). Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection. Therapeutic advances in medical oncology, Vol.10, pp. 175883591877742-175883591877742.  show abstract

Arce Vargas, F. Furness, A.J. Litchfield, K. Joshi, K. Rosenthal, R. Ghorani, E. Solomon, I. Lesko, M.H. Ruef, N. Roddie, C. Henry, J.Y. Spain, L. Ben Aissa, A. Georgiou, A. Wong, Y.N. Smith, M. Strauss, D. Hayes, A. Nicol, D. O'Brien, T. Mårtensson, L. Ljungars, A. Teige, I. Frendéus, B. Pule, M. Marafioti, T. Gore, M. Larkin, J. Turajlic, S. Swanton, C. Peggs, K.S. Quezada, S.A. Harrington, K. Melcher, A. Wotherspoon, A. Francis, N. Challacombe, B. Fernando, A. Hazell, S. Chandra, A. Pickering, L. Lynch, J. Rudman, S. Chowdhury, S. Harrison-Phipps, K. Varia, M. Horsfield, C. Polson, A. Stamp, G. O'Donnell, M. Drake, W. Hill, P. Hrouda, D. Mayer, E. Olsburgh, J. Kooiman, G. O'Connor, K. Stewart, G. Aitchison, M. Tran, M. Fotiadis, N. Verma, H. Lopez, J. Lester, J. Morgan, F. Kornaszewska, M. Attanoos, R. Adams, H. Davies, H. Fennell, D. Shaw, J. Le Quesne, J. Nakas, A. Rathinam, S. Monteiro, W. Marshall, H. Nelson, L. Bennett, J. Riley, J. Primrose, L. Martinson, L. Anand, G. Khan, S. Nicolson, M. Kerr, K. Palmer, S. Remmen, H. Miller, J. Buchan, K. Chetty, M. Gomersall, L. Lock, S. Naidu, B. Langman, G. Trotter, S. Bellamy, M. Bancroft, H. Kerr, A. Kadiri, S. Webb, J. Middleton, G. Djearaman, M. Summers, Y. Califano, R. Taylor, P. Shah, R. Krysiak, P. Rammohan, K. Fontaine, E. Booton, R. Evison, M. Crosbie, P. Moss, S. Idries, F. Novasio, J. Joseph, L. Bishop, P. Chaturvedi, A. Marie Quinn, A. Doran, H. leek, A. Harrison, P. Moore, K. Waddington, R. Blackhall, F. Rogan, J. Smith, E. Dive, C. Brady, G. Rothwell, D. Gulati, S. Chemie, F. Tugwood, J. Pierce, J. Lawrence, D. Hayward, M. Panagiotopoulos, N. George, R. Patrini, D. Falzon, M. Borg, E. Khiroya, R. Jamal-Hanjani, M. Wilson, G. Juul Birkbak, N. Watkins, T. McGranahan, N. Abbosh, C. Horswell, S. Mitter, R. Escudero, M. Stewart, A. Rowan, A. Hiley, C. Goldman, J. Ahmed, A. Taylor, M. Choudhary, J. Shaw, P. Veeriah, R. Czyzewska-Khan, J. Johnson, D. Laycock, J. Hynds, R. Werner Sunderland, M. Reading, J. Novelli, M. Oukrif, D. Janes, S. Forster, M. Ahmad, T. Ming Lee, S. van Loo, P. Herrero, J. Hartley, J. Kevin Stone, R. Denner, T. Costa, M. Begum, S. Phillimore, B. Chambers, T. Nye, E. Ward, S. Elgar, G. Al-Bakir, M. Carnell, D. Mendes, R. George, J. Navani, N. Papadatos-Pastos, D. Scarci, M. Gorman, P. Lowe, H. Ensell, L. Moore, D. MacKenzie, M. Wilcox, M. Bell, H. Hackshaw, A. Ngai, Y. Smith, S. Gower, N. Ottensmeier, C. Chee, S. Johnson, B. Alzetani, A. Shaw, E. Lim, E. De Sousa, P. Tavares Barbosa, M. Nicholson, A. Bowman, A. Jordan, S. Rice, A. Raubenheimer, H. Proli, C. Elena Cufari, M. Carlo Ronquillo, J. Kwayie, A. Bhayani, H. Hamilton, M. Bakar, Y. Mensah, N. Ambrose, L. Devaraj, A. Buderi, S. Finch, J. Azcarate, L. Chavan, H. Green, S. Mashinga, H. Lau, K. Sheaff, M. Schmid, P. Conibear, J. Ezhil, V. Prakash, V. Danson, S. Bury, J. Edwards, J. Hill, J. Matthews, S. Kitsanta, Y. Suvarna, K. Shackcloth, M. Gosney, J. Postmus, P. Feeney, S. Asante-Siaw, J. Russell, P. Light, T. Horey, T. Blyth, K. Dick, C. Kirk, A. (2018). Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. Cancer cell, Vol.33 (4), pp. 649-663.e4.

Turajlic, S. Xu, H. Litchfield, K. Rowan, A. Horswell, S. Chambers, T. O’Brien, T. Lopez, J.I. Watkins, T.B. Nicol, D. Stares, M. Challacombe, B. Hazell, S. Chandra, A. Mitchell, T.J. Au, L. Eichler-Jonsson, C. Jabbar, F. Soultati, A. Chowdhury, S. Rudman, S. Lynch, J. Fernando, A. Stamp, G. Nye, E. Stewart, A. Xing, W. Smith, J.C. Escudero, M. Huffman, A. Matthews, N. Elgar, G. Phillimore, B. Costa, M. Begum, S. Ward, S. Salm, M. Boeing, S. Fisher, R. Spain, L. Navas, C. Grönroos, E. Hobor, S. Sharma, S. Aurangzeb, I. Lall, S. Polson, A. Varia, M. Horsfield, C. Fotiadis, N. Pickering, L. Schwarz, R.F. Silva, B. Herrero, J. Luscombe, N.M. Jamal-Hanjani, M. Rosenthal, R. Birkbak, N.J. Wilson, G.A. Pipek, O. Ribli, D. Krzystanek, M. Csabai, I. Szallasi, Z. Gore, M. McGranahan, N. Van Loo, P. Campbell, P. Larkin, J. Swanton, C. (2018). Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal. Cell, Vol.173 (3), pp. 595-610.e11.

Turajlic, S. Xu, H. Litchfield, K. Rowan, A. Chambers, T. Lopez, J.I. Nicol, D. O’Brien, T. Larkin, J. Horswell, S. Stares, M. Au, L. Jamal-Hanjani, M. Challacombe, B. Chandra, A. Hazell, S. Eichler-Jonsson, C. Soultati, A. Chowdhury, S. Rudman, S. Lynch, J. Fernando, A. Stamp, G. Nye, E. Jabbar, F. Spain, L. Lall, S. Guarch, R. Falzon, M. Proctor, I. Pickering, L. Gore, M. Watkins, T.B. Ward, S. Stewart, A. DiNatale, R. Becerra, M.F. Reznik, E. Hsieh, J.J. Richmond, T.A. Mayhew, G.F. Hill, S.M. McNally, C.D. Jones, C. Rosenbaum, H. Stanislaw, S. Burgess, D.L. Alexander, N.R. Swanton, C. (2018). Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell, Vol.173 (3), pp. 581-594.e12.

Mitchell, T.J. Turajlic, S. Rowan, A. Nicol, D. Farmery, J.H. O’Brien, T. Martincorena, I. Tarpey, P. Angelopoulos, N. Yates, L.R. Butler, A.P. Raine, K. Stewart, G.D. Challacombe, B. Fernando, A. Lopez, J.I. Hazell, S. Chandra, A. Chowdhury, S. Rudman, S. Soultati, A. Stamp, G. Fotiadis, N. Pickering, L. Au, L. Spain, L. Lynch, J. Stares, M. Teague, J. Maura, F. Wedge, D.C. Horswell, S. Chambers, T. Litchfield, K. Xu, H. Stewart, A. Elaidi, R. Oudard, S. McGranahan, N. Csabai, I. Gore, M. Futreal, P.A. Larkin, J. Lynch, A.G. Szallasi, Z. Swanton, C. Campbell, P.J. (2018). Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal. Cell, Vol.173 (3), pp. 611-623.e17.

Tio, M. Rai, R. Ezeoke, O.M. McQuade, J.L. Zimmer, L. Khoo, C. Park, J.J. Spain, L. Turajlic, S. Ardolino, L. Yip, D. Goldinger, S.M. Cohen, J.V. Millward, M. Atkinson, V. Kane, A.Y. Ascierto, P.A. Garbe, C. Gutzmer, R. Johnson, D.B. Rizvi, H.A. Joshua, A.M. Hellmann, M.D. Long, G.V. Menzies, A.M. (2018). Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection. European journal of cancer, Vol.104, pp. 137-144.

Turajlic, S. Larkin, J. (2018). Immunotherapy for Melanoma Metastatic to the Brain. New england journal of medicine, Vol.379 (8), pp. 789-790.

Lim, K.J. Spain, L. Barker, C. Georgiou, A. Walls, G. Gore, M. Turajlic, S. Board, R. Larkin, J.M. Lorigan, P. (2018). Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma. Esmo open, Vol.3 (2), pp. e000317-e000317.

Spain, L. Walls, G. Messiou, C. Turajlic, S. Gore, M. Larkin, J. (2017). Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series. Cancer immunology, immunotherapy, Vol.66 (1), pp. 113-117.

Spain, L. Walls, G. Julve, M. O’Meara, K. Schmid, T. Kalaitzaki, E. Turajlic, S. Gore, M. Rees, J. Larkin, J. (2017). Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature. Annals of oncology, Vol.28 (2), pp. 377-385.

Arce Vargas, F. Furness, A.J. Solomon, I. Joshi, K. Mekkaoui, L. Lesko, M.H. Miranda Rota, E. Dahan, R. Georgiou, A. Sledzinska, A. Ben Aissa, A. Franz, D. Werner Sunderland, M. Wong, Y.N. Henry, J.Y. O’Brien, T. Nicol, D. Challacombe, B. Beers, S.A. Turajlic, S. Gore, M. Larkin, J. Swanton, C. Chester, K.A. Pule, M. Ravetch, J.V. Marafioti, T. Peggs, K.S. Quezada, S.A. Spain, L. Wotherspoon, A. Francis, N. Smith, M. Strauss, D. Hayes, A. Soultati, A. Stares, M. Spain, L. Lynch, J. Fotiadis, N. Fernando, A. Hazell, S. Chandra, A. Pickering, L. Rudman, S. Chowdhury, S. Swanton, C. Jamal-Hanjani, M. Veeriah, S. Shafi, S. Czyzewska-Khan, J. Johnson, D. Laycock, J. Bosshard-Carter, L. Goh, G. Rosenthal, R. Gorman, P. Murugaesu, N. Hynds, R.E. Wilson, G. Birkbak, N.J. Watkins, T.B. McGranahan, N. Horswell, S. Mitter, R. Escudero, M. Stewart, A. Van Loo, P. Rowan, A. Xu, H. Turajlic, S. Hiley, C. Abbosh, C. Goldman, J. Stone, R.K. Denner, T. Matthews, N. Elgar, G. Ward, S. Biggs, J. Costa, M. Begum, S. Phillimore, B. Chambers, T. Nye, E. Graca, S. Al Bakir, M. Hartley, J.A. Lowe, H.L. Herrero, J. Lawrence, D. Hayward, M. Panagiotopoulos, N. Kolvekar, S. Falzon, M. Borg, E. Simeon, C. Hector, G. Smith, A. Aranda, M. Novelli, M. Oukrif, D. Janes, S.M. Thakrar, R. Forster, M. Ahmad, T. Lee, S.M. Papadatos-Pastos, D. Carnell, D. Mendes, R. George, J. Navani, N. Ahmed, A. Taylor, M. Choudhary, J. Summers, Y. Califano, R. Taylor, P. Shah, R. Krysiak, P. Rammohan, K. Fontaine, E. Booton, R. Evison, M. Crosbie, P. Moss, S. Idries, F. Joseph, L. Bishop, P. Chaturved, A. Quinn, A.M. Doran, H. Leek, A. Harrison, P. Moore, K. Waddington, R. Novasio, J. Blackhall, F. Rogan, J. Smith, E. Dive, C. Tugwood, J. Brady, G. Rothwell, D.G. Chemi, F. Pierce, J. Gulati, S. Naidu, B. Langman, G. Trotter, S. Bellamy, M. Bancroft, H. Kerr, A. Kadiri, S. Webb, J. Middleton, G. Djearaman, M. Fennell, D. Shaw, J.A. Le Quesne, J. Moore, D. Nakas, A. Rathinam, S. Monteiro, W. Marshall, H. Nelson, L. Bennett, J. Riley, J. Primrose, L. Martinson, L. Anand, G. Khan, S. Amadi, A. Nicolson, M. Kerr, K. Palmer, S. Remmen, H. Miller, J. Buchan, K. Chetty, M. Gomersall, L. Lester, J. Edwards, A. Morgan, F. Adams, H. Davies, H. Kornaszewska, M. Attanoos, R. Lock, S. Verjee, A. MacKenzie, M. Wilcox, M. Bell, H. Iles, N. Hackshaw, A. Ngai, Y. Smith, S. Gower, N. Ottensmeier, C. Chee, S. Johnson, B. Alzetani, A. Shaw, E. Lim, E. De Sousa, P. Barbosa, M.T. Bowman, A. Jorda, S. Rice, A. Raubenheimer, H. Proli, C. Cufari, M.E. Ronquillo, J.C. Kwayie, A. Bhayani, H. Hamilton, M. Bakar, Y. Mensah, N. Ambrose, L. Devaraj, A. Buderi, S. Finch, J. Azcarate, L. Chavan, H. Green, S. Mashinga, H. Nicholson, A.G. Lau, K. Sheaff, M. Schmid, P. Conibear, J. Ezhil, V. Ismail, B. Irvin-sellers, M. Prakash, V. Russell, P. Light, T. Horey, T. Danson, S. Bury, J. Edwards, J. Hill, J. Matthews, S. Kitsanta, Y. Suvarna, K. Fisher, P. Keerio, A.D. Shackcloth, M. Gosney, J. Postmus, P. Feeney, S. Asante-Siaw, J. (2017). Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors. Immunity, Vol.46 (4), pp. 577-586.

Jamal-Hanjani, M. Wilson, G.A. McGranahan, N. Birkbak, N.J. Watkins, T.B. Veeriah, S. Shafi, S. Johnson, D.H. Mitter, R. Rosenthal, R. Salm, M. Horswell, S. Escudero, M. Matthews, N. Rowan, A. Chambers, T. Moore, D.A. Turajlic, S. Xu, H. Lee, S.-. Forster, M.D. Ahmad, T. Hiley, C.T. Abbosh, C. Falzon, M. Borg, E. Marafioti, T. Lawrence, D. Hayward, M. Kolvekar, S. Panagiotopoulos, N. Janes, S.M. Thakrar, R. Ahmed, A. Blackhall, F. Summers, Y. Shah, R. Joseph, L. Quinn, A.M. Crosbie, P.A. Naidu, B. Middleton, G. Langman, G. Trotter, S. Nicolson, M. Remmen, H. Kerr, K. Chetty, M. Gomersall, L. Fennell, D.A. Nakas, A. Rathinam, S. Anand, G. Khan, S. Russell, P. Ezhil, V. Ismail, B. Irvin-Sellers, M. Prakash, V. Lester, J.F. Kornaszewska, M. Attanoos, R. Adams, H. Davies, H. Dentro, S. Taniere, P. O’Sullivan, B. Lowe, H.L. Hartley, J.A. Iles, N. Bell, H. Ngai, Y. Shaw, J.A. Herrero, J. Szallasi, Z. Schwarz, R.F. Stewart, A. Quezada, S.A. Le Quesne, J. Van Loo, P. Dive, C. Hackshaw, A. Swanton, C. (2017). Tracking the Evolution of Non–Small-Cell Lung Cancer. New england journal of medicine, Vol.376 (22), pp. 2109-2121.

Turajlic, S. Swanton, C. (2017). Implications of cancer evolution for drug development. Nature reviews drug discovery, Vol.16 (7), pp. 441-442.

Turajlic, S. Litchfield, K. Xu, H. Rosenthal, R. McGranahan, N. Reading, J.L. Wong, Y.N. Rowan, A. Kanu, N. Al Bakir, M. Chambers, T. Salgado, R. Savas, P. Loi, S. Birkbak, N.J. Sansregret, L. Gore, M. Larkin, J. Quezada, S.A. Swanton, C. (2017). Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis. The lancet oncology, Vol.18 (8), pp. 1009-1021.

Litchfield, K. Turajlic, S. Swanton, C. (2017). The GENIE Is Out of the Bottle: Landmark Cancer Genomics Dataset Released. Cancer discovery, Vol.7 (8), pp. 796-798.

(2017). TRACERx Renal: tracking renal cancer evolution through therapy. Nature reviews urology, Vol.14 (10), pp. 575-576.

McGranahan, N. Rosenthal, R. Hiley, C.T. Rowan, A.J. Watkins, T.B. Wilson, G.A. Birkbak, N.J. Veeriah, S. Van Loo, P. Herrero, J. Swanton, C. Swanton, C. Jamal-Hanjani, M. Veeriah, S. Shafi, S. Czyzewska-Khan, J. Johnson, D. Laycock, J. Bosshard-Carter, L. Rosenthal, R. Gorman, P. Hynds, R.E. Wilson, G. Birkbak, N.J. Watkins, T.B. McGranahan, N. Horswell, S. Mitter, R. Escudero, M. Stewart, A. Van Loo, P. Rowan, A. Xu, H. Turajlic, S. Hiley, C. Abbosh, C. Goldman, J. Stone, R.K. Denner, T. Matthews, N. Elgar, G. Ward, S. Costa, M. Begum, S. Phillimore, B. Chambers, T. Nye, E. Graca, S. Al Bakir, M. Joshi, K. Furness, A. Ben Aissa, A. Wong, Y.N. Georgiou, A. Quezada, S. Hartley, J.A. Lowe, H.L. Herrero, J. Lawrence, D. Hayward, M. Panagiotopoulos, N. Kolvekar, S. Falzon, M. Borg, E. Marafioti, T. Simeon, C. Hector, G. Smith, A. Aranda, M. Novelli, M. Oukrif, D. Janes, S.M. Thakrar, R. Forster, M. Ahmad, T. Lee, S.M. Papadatos-Pastos, D. Carnell, D. Mendes, R. George, J. Navani, N. Ahmed, A. Taylor, M. Choudhary, J. Summers, Y. Califano, R. Taylor, P. Shah, R. Krysiak, P. Rammohan, K. Fontaine, E. Booton, R. Evison, M. Crosbie, P. Moss, S. Idries, F. Joseph, L. Bishop, P. Chaturved, A. Quinn, A.M. Doran, H. Leek, A. Harrison, P. Moore, K. Waddington, R. Novasio, J. Blackhall, F. Rogan, J. Smith, E. Dive, C. Tugwood, J. Brady, G. Rothwell, D.G. Chemi, F. Pierce, J. Gulati, S. Naidu, B. Langman, G. Trotter, S. Bellamy, M. Bancroft, H. Kerr, A. Kadiri, S. Webb, J. Middleton, G. Djearaman, M. Fennell, D. Shaw, J.A. Le Quesne, J. Moore, D. Nakas, A. Rathinam, S. Monteiro, W. Marshall, H. Nelson, L. Bennett, J. Riley, J. Primrose, L. Martinson, L. Anand, G. Khan, S. Amadi, A. Nicolson, M. Kerr, K. Palmer, S. Remmen, H. Miller, J. Buchan, K. Chetty, M. Gomersall, L. Lester, J. Edwards, A. Morgan, F. Adams, H. Davies, H. Kornaszewska, M. Attanoos, R. Lock, S. Verjee, A. MacKenzie, M. Wilcox, M. Bell, H. Hackshaw, A. Ngai, Y. Smith, S. Gower, N. Ottensmeier, C. Chee, S. Johnson, B. Alzetani, A. Shaw, E. Lim, E. De Sousa, P. Barbosa, M.T. Bowman, A. Jordan, S. Rice, A. Raubenheimer, H. Proli, C. Cufari, M.E. Ronquillo, J.C. Kwayie, A. Bhayani, H. Hamilton, M. Bakar, Y. Mensah, N. Ambrose, L. Devaraj, A. Buderi, S. Finch, J. Azcarate, L. Chavan, H. Green, S. Mashinga, H. Nicholson, A.G. Lau, K. Sheaff, M. Schmid, P. Conibear, J. Ezhil, V. Ismail, B. Irvin-sellers, M. Prakash, V. Russell, P. Light, T. Horey, T. Danson, S. Bury, J. Edwards, J. Hill, J. Matthews, S. Kitsanta, Y. Suvarna, K. Fisher, P. Keerio, A.D. Shackcloth, M. Gosney, J. Postmus, P. Feeney, S. Asante-Siaw, J. Aerts, H.J. Dentro, S. Dessimoz, C. (2017). Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. Cell, Vol.171 (6), pp. 1259-1271.e11.

Abbosh, C. Birkbak, N.J. Wilson, G.A. Jamal-Hanjani, M. Constantin, T. Salari, R. Le Quesne, J. Moore, D.A. Veeriah, S. Rosenthal, R. Marafioti, T. Kirkizlar, E. Watkins, T.B. McGranahan, N. Ward, S. Martinson, L. Riley, J. Fraioli, F. Al Bakir, M. Grönroos, E. Zambrana, F. Endozo, R. Bi, W.L. Fennessy, F.M. Sponer, N. Johnson, D. Laycock, J. Shafi, S. Czyzewska-Khan, J. Rowan, A. Chambers, T. Matthews, N. Turajlic, S. Hiley, C. Lee, S.M. Forster, M.D. Ahmad, T. Falzon, M. Borg, E. Lawrence, D. Hayward, M. Kolvekar, S. Panagiotopoulos, N. Janes, S.M. Thakrar, R. Ahmed, A. Blackhall, F. Summers, Y. Hafez, D. Naik, A. Ganguly, A. Kareht, S. Shah, R. Joseph, L. Marie Quinn, A. Crosbie, P.A. Naidu, B. Middleton, G. Langman, G. Trotter, S. Nicolson, M. Remmen, H. Kerr, K. Chetty, M. Gomersall, L. Fennell, D.A. Nakas, A. Rathinam, S. Anand, G. Khan, S. Russell, P. Ezhil, V. Ismail, B. Irvin-Sellers, M. Prakash, V. Lester, J.F. Kornaszewska, M. Attanoos, R. Adams, H. Davies, H. Oukrif, D. Akarca, A.U. Hartley, J.A. Lowe, H.L. Lock, S. Iles, N. Bell, H. Ngai, Y. Elgar, G. Szallasi, Z. Schwarz, R.F. Herrero, J. Stewart, A. Quezada, S.A. Peggs, K.S. Van Loo, P. Dive, C. Lin, C.J. Rabinowitz, M. Aerts, H.J. Hackshaw, A. Shaw, J.A. Zimmermann, B.G. Swanton, C. (2017). Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature, Vol.545 (7655), pp. 446-451.

Spain, L. Higgins, R. Gopalakrishnan, K. Turajlic, S. Gore, M. Larkin, J. (2016). Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma. Annals of oncology, Vol.27 (6), pp. 1135-1137.

Turajlic, S. Swanton, C. (2016). Metastasis as an evolutionary process. Science, Vol.352 (6282), pp. 169-175.

Turajlic, S. Larkin, J. (2016). Systemic treatment of advanced papillary renal cell carcinoma: Where next?. European journal of cancer, Vol.69, pp. 223-225.

Spain, L. Walls, G. Julve, M. O'Meara, K. Schmid, T. Kalaitzaki, E. Turajlic, S. Gore, M. Rees, J. Larkin, J. (2016). Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature. Ann oncol, .

Turajlic, S. McGranahan, N. Swanton, C. (2015). Inferring mutational timing and reconstructing tumour evolutionary histories. Biochimica et biophysica acta (bba) - reviews on cancer, Vol.1855 (2), pp. 264-275.

Gulati, S. Turajlic, S. Larkin, J. Bates, P.A. Swanton, C. (2015). Relapse models for clear cell renal carcinoma. The lancet oncology, Vol.16 (8), pp. e376-e378.

Soultati, A. Stares, M. Swanton, C. Larkin, J. Turajlic, S. (2015). How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?. Current opinion in urology, Vol.25 (5), pp. 358-366.

Turajlic, S. Larkin, J. Swanton, C. (2015). Academically led clinical trials: challenges and opportunities. Annals of oncology, Vol.26 (10), pp. 2010-2011.

Turajlic, S. Swanton, C. (2015). Tracking tumour evolution through liquid biopsy. Nature reviews clinical oncology, Vol.12 (10), pp. 565-566.

Turajlic, S. Larkin, J. Swanton, C. (2015). SnapShot: Renal Cell Carcinoma. Cell, Vol.163 (6), pp. 1556-1556.e1.

Turajlic, S. Furney, S.J. Stamp, G. Rana, S. Ricken, G. Oduko, Y. Saturno, G. Springer, C. Hayes, A. Gore, M. Larkin, J. Marais, R. (2014). Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition. Annals of oncology, Vol.25 (5), pp. 959-967.

Furney, S.J. Turajlic, S. Stamp, G. Thomas, J.M. Hayes, A. Strauss, D. Gavrielides, M. Xing, W. Gore, M. Larkin, J. Marais, R. (2014). The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Pigment cell & melanoma research, Vol.27 (5), pp. 835-838.

Sanchez-Laorden, B. Viros, A. Girotti, M.R. Pedersen, M. Saturno, G. Zambon, A. Niculescu-Duvaz, D. Turajlic, S. Hayes, A. Gore, M. Larkin, J. Lorigan, P. Cook, M. Springer, C. Marais, R. (2014). BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells by Reactivating MEK and ERK Signaling. Science signaling, Vol.7 (318), pp. ra30-ra30.

Girotti, M.R. Pedersen, M. Sanchez-Laorden, B. Viros, A. Turajlic, S. Niculescu-Duvaz, D. Zambon, A. Sinclair, J. Hayes, A. Gore, M. Lorigan, P. Springer, C. Larkin, J. Jorgensen, C. Marais, R. (2013). Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma. Cancer discovery, Vol.3 (2), pp. 158-167.

Khattak, M. Fisher, R. Turajlic, S. Larkin, J. (2013). Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm. Therapeutic advances in medical oncology, Vol.5 (2), pp. 105-118.

Furney, S.J. Turajlic, S. Stamp, G. Nohadani, M. Carlisle, A. Thomas, J.M. Hayes, A. Strauss, D. Gore, M. van den Oord, J. Larkin, J. Marais, R. (2013). Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. The journal of pathology, Vol.230 (3), pp. 261-269.

Turajlic, S. Ali, Z. Yousaf, N. Larkin, J. (2013). Phase I/II RAF kinase inhibitors in cancer therapy. Expert opinion on investigational drugs, Vol.22 (6), pp. 739-749.

Furney, S.J. Pedersen, M. Gentien, D. Dumont, A.G. Rapinat, A. Desjardins, L. Turajlic, S. Piperno-Neumann, S. de la Grange, P. Roman-Roman, S. Stern, M.-. Marais, R. (2013). SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma. Cancer discovery, Vol.3 (10), pp. 1122-1129.

Turajlic, S. Furney, S.J. Lambros, M.B. Mitsopoulos, C. Kozarewa, I. Geyer, F.C. MacKay, A. Hakas, J. Zvelebil, M. Lord, C.J. Ashworth, A. Thomas, M. Stamp, G. Larkin, J. Reis-Filho, J.S. Marais, R. (2012). Whole genome sequencing of matched primary and metastatic acral melanomas. Genome research, Vol.22 (2), pp. 196-207.

Natrajan, R. Mackay, A. Lambros, M.B. Weigelt, B. Wilkerson, P.M. Manie, E. Grigoriadis, A. A'Hern, R. van der Groep, P. Kozarewa, I. Popova, T. Mariani, O. Turajlic, S. Furney, S.J. Marais, R. Rodruigues, D.-. Flora, A.C. Wai, P. Pawar, V. McDade, S. Carroll, J. Stoppa-Lyonnet, D. Green, A.R. Ellis, I.O. Swanton, C. van Diest, P. Delattre, O. Lord, C.J. Foulkes, W.D. Vincent-Salomon, A. Ashworth, A. Stern, M.H. Reis-Filho, J.S. (2012). A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers. The journal of pathology, Vol.227 (1), pp. 29-41.

Furney, S.J. Turajlic, S. Fenwick, K. Lambros, M.B. MacKay, A. Ricken, G. Mitsopoulos, C. Kozarewa, I. Hakas, J. Zvelebil, M. Lord, C.J. Ashworth, A. Reis-Filho, J.S. Herlyn, M. Murata, H. Marais, R. (2012). Genomic characterisation of acral melanoma cell lines. Pigment cell & melanoma research, Vol.25 (4), pp. 488-492.

Larkin, J.M. Turajlic, S. Nathan, P.D. Lorigan, P. Stamp, G. Gonzalez de Castro, D. Martin, N. Griffiths, J. Edmonds, K. Sarker, S. James, M.G. A'Hern, R. Coombes, G. Snowdon, C. Bliss, J.M. Gore, M.E. Marais, R. (2011). A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM). J clin oncol, Vol.29 (15_suppl), p. TPS229.  show abstract

Perez, A. Turajlic, S. Szyszko, T. O'Doherty, M. Calonje, E. Harries, M. Acland, K. (2010). Generalized melanosis and melanuria in a patient with metastatic melanoma. Clinical and experimental dermatology, Vol.35 (3), pp. e37-e39.

Ferronika, P. Hof, J. Kats-Ugurlu, G. Sijmons, R.H. Terpstra, M.M. de Lange, K. Leliveld-Kors, A. Westers, H. Kok, K. Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour. Cancers, Vol.11 (6), pp. 812-812.  show abstract

Litchfield, K. Reading, J.L. Puttick, C. Abbosh, C. Bentham, R. Watkins, T.B. Rosenthal, R. Biswas, D. Lim, E. AL-Bakir, M. Turati, V. Guerra-Assunção, J.A. Conde, L. Furness, A.J. Saini, S.K. Hadrup, S.R. Herrero, J. Rowan, A. Enver, T. Hellmann, M.D. Larkin, J. Turajlic, S. Quezada, S. McGranahan, N. Swanton, C. Meta-analysis of tumor and T cell intrinsic mechanisms of sensitization to checkpoint inhibition. , .  show abstract

Carbone, F. Huang, J.K. Perelli, L. Poggetto, E.D. Gutschner, T. Tomihara, H. Soeung, M. Lam, T.N. Xia, R. Zhu, C. Song, X. Zhang, J. Sircar, K. Malouf, G.G. Sgambato, A. Karam, J.A. Gao, J. Jonasch, E. Viale, A. Draetta, G.F. Futreal, A. Bakouny, Z. Van Allen, E.M. Choueiri, T. Msaouel, P. Litchfield, K. Turajlic, S. Heffernan, T.P. Chen, Y.B. DiNatale, R.G. Hakimi, A.A. Bristow, C.A. Tannir, N.M. Carugo, A. Genovese, G. 9p21 Loss Defines the Evolutionary Patterns of Aggressive Renal Cell Carcinomas. , .  show abstract

Hodzic, E. Shrestha, R. Malikic, S. Collins, C.C. Litchfield, K. Turajlic, S. Sahinalp, S.C. Identification of Conserved Evolutionary Trajectories in Tumors. , .  show abstract

Fendler, A. Au, L. Boos, L.A. Byrne, F. Shepherd, S.T. Shum, B. Gerard, C.L. Ward, B. Xie, W. Cerrone, M. Cornish, G.H. Pule, M. Mekkaoui, L. Ng, K.W. Stone, R. Gomes, C. Flynn, H.R. Agua-Doce, A. Hobson, P. Caidan, S. Howell, M. Goldstone, R. Gavrielides, M. Nye, E. Snijders, B. Macrae, J. Nicod, J. Hayday, A. Gronthoud, F. Messiou, C. Cunningham, D. Chau, I. Starling, N. Turner, N. Rusby, J. Welsh, L. van As, N. Jones, R. Droney, J. Banerjee, S. Tatham, K. Jhanji, S. O’Brien, M. Curtis, O. Harrington, K. Bhide, S. Slattery, T. Khan, Y. Tippu, Z. Leslie, I. Gennatas, S. Okines, A. Reid, A. Young, K. Furness, A. Pickering, L. Ghandi, S. Gamblin, S. Swanton, C. Nicholson, E. Kumar, S. Yousaf, N. Wilkinson, K. Swerdlow, A. Harvey, R. Kassiotis, G. Wilkinson, R. Larkin, J. Turajlic, S. Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study. , .  show abstract

Zhao, Y. Fu, X. Lopez, J. Rowan, A. Au, L. Fendler, A. Hazell, S. Xu, H. Horswell, S. Shephard, S. Spain, L. Byrne, F. Stamp, G. O'Brien, T. Nicol, D. Augustine, M. Chandra, A. Rudman, S. Toncheva, A. Pickering, L. Larkin, J. Sahai, E. Bates, P. Swanton, C. Turajlic, S. Litchfield, K. Selection of metastasis competent subclones in the tumour interior: TRACERx renal. , .  show abstract

Fu, X. Zhao, Y. Lopez, J. Rowan, A. Au, L. Fendler, A. Hazell, S. Xu, H. Horswell, S. Shepherd, S. Spain, L. Byrne, F. Stamp, G. O'Brien, T. Nicol, D. Augustine, M. Chandra, A. Rudman, S. Toncheva, A. Furness, A. Pickering, L. Orton, M. Doran, S. Koh, D.-. Messiou, C. Dafydd, D.A. Kumar, S. Larkin, J. Swanton, C. Sahai, E. Litchfield, K. Turajlic, S. Bates, P. Spatial patterns of tumour growth impact clonal diversification: computational modelling and evidence in the TRACERx Renal study. , .  show abstract

Buck, M.D. Poirier, E.Z. Cardoso, A. Frederico, B. Canton, J. Barrell, S. Beale, R. Byrne, R. Caidan, S. Crawford, M. Cubitt, L. Gandhi, S. Goldstone, R. Grant, P.R. Gulati, K. Hindmarsh, S. Howell, M. Hubank, M. Instrell, R. Jiang, M. Kassiotis, G. Lu, W.-. MacRae, J.I. Martini, I. Miller, D. Moore, D. Nastouli, E. Nicod, J. Nightingale, L. Olsen, J. Oomatia, A. O'Reilly, N. Rideg, A. Song, O.-. Strange, A. Swanton, C. Turajlic, S. Wu, M. Reis e Sousa, C. SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay. Wellcome open research, Vol.6, pp. 9-9.  show abstract


Conferences

Scherrer, E.Hair, G.M.Mt-Isa, S.Pereira, M.Chan, G.Shui, I.Arumugam, P.Zarowiecki, M.Witkowska, K.Rahim, T.Turajlic, S.Litchfield, K.R.Lorigan, P.Larkin, J. (2020). 1136P Feasibility of linking the UK 100,000 genomes project and real-world evidence databases for a melanoma patient population, Annals of Oncology, Vol.31, pp.S760-S761.

Zhao, Y.Rowan, A.Lopez, J.I.Swanton, C.Turajlic, S.Litchfield, K.R. (2020). 703MO An integrated study of spatial dynamics and genomic alterations in renal cell carcinoma evolution, Annals of Oncology, Vol.31, pp.S554-S555.

Kotsiou, E.Hou, T.Z.Robinson, J.Varsani, S.Oakes, T.Becker, P.D.Patel, S.Mootien, J.Craig, A.Robertson, J.Samuel, E.Reading, J.Rosario, L.D.Haynes, A.Turajlic, S.Islam, F.Lawrence, D.Jamal-Hanjani, M.Foster, M.Quezada, S.A.Newton, K. (2020). Abstract 875: Next generation clonal neoantigen targeting T cells, generated using the PELEUSTMbioinformatics platform and the VELOSTMmanufacturing method show superior reactivity and phenotypic characteristics than classical TIL products, Presented at Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA, Immunology, .

Fraser, H.Pike, R.Thirkell, S.Arshad, A.Jide-Banwo, S.Bartley, H.Rologi, E.Pruchniak, M.Patel, S.Mootien, J.Robertson, J.Craig, A.Salm, M.Newton, K.Goodsell, L.Chan, F.Wilson, G.Frenk, S.Ali, I.Peggs, K.Lowdell, M.W.Del Rosio, L.Hayes, A.Turajlic, S.Islam, F.Lawrence, D.Jamal-Hanjani, M.Forster, M.D.Samuel, E. (2020). Abstract CT054: The development of a personalized autologous clonal neoantigen T cell therapy for the treatment of solid cancer using the VELOSTMmanufacturing platform generates highly potent and reactive CD8+ and CD4+ T cells for clinical use, Presented at Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA, Tumor Biology, .

Fendler, A.Boos, L.Au, L.Shepherd, S.Byrne, F.Edmonds, K.Carlyle, E.Rosario, L.D.Shum, B.Larkin, J.Pickering, L.Furness, A.Turajlic, S. (2020). Abstract PO-091: CAPTURE: Cancer and COVID-19 antiviral immune monitoring study, Presented at AACR Virtual Meeting: COVID-19 and Cancer; July 20-22, 2020, Poster Presentations - Proffered Abstracts, .

Girotti, M.R.Pedersen, M.Sanchez-Laorden, B.Viros, A.Turajlic, S.Niculescu-Duvaz, D.Zambon, A.Sinclair, J.Hayes, A.Gore, M.Springer, C.Larkin, J.Jorgensen, C.Marais, R. (2013). Abstract 3404: Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma., Presented at Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC, Experimental and Molecular Therapeutics, .

Larkin, J.M.Turajlic, S.Nathan, P.D.Lorigan, P.Stamp, G.Gonzalez de Castro, D.Martin, N.Griffiths, J.Edmonds, K.Sarker, S.James, M.G.A'Hern, R.Coombes, G.Snowdon, C.Bliss, J.M.Gore, M.E.Marais, R. (2011). A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM)., Journal of Clinical Oncology, Vol.29 (15_suppl), p.TPS229.

In this section

Research overview Research projects Publications